عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.

NCR graphs - Incidence rates by year

- All cancer including non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer including non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- All cancer excluding non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer excluding non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Oesophagus cancer, crude incidence rate, males, 2005-2015
- Oesophagus cancer, crude incidence rate, females, 2005-2015

- Stomach cancer, crude incidence rate, males, 2005-2015
- Stomach cancer, crude incidence rate, females, 2005-2015

- Colo-rectal cancer, crude incidence rate, males, 2005-2015
- Colo-rectal cancer, crude incidence rate, females, 2005-2015

- Liver cancer, crude incidence rate, males, 2005-2015
- Liver cancer, crude incidence rate, females, 2005-2015

- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, males, 2005-2015
- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, females, 2005-2015

- Pancreas cancer, crude incidence rate, males, 2005-2015
- Pancreas cancer, crude incidence rate, females, 2005-2015

- Larynx cancer, crude incidence rate, males, 2005-2015
- Larynx cancer, crude incidence rate, females, 2005-2015

- Trachea-bronchus-lung cancer, crude incidence rate, males, 2005-2015
- Trachea-bronchus-lung cancer, crude incidence rate, females, 2005-2015

- Bone cancer, crude incidence rate, males, 2005-2015
- Bone cancer, crude incidence rate, females, 2005-2015

- Melanoma, crude incidence rate, males, 2005-2015
- Melanoma, crude incidence rate, females, 2005-2015

- Non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- Non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Mesothelioma, crude incidence rate, males, 2005-2015
- Mesothelioma, crude incidence rate, females, 2005-2015

- Breast cancer, crude incidence rate, males, 2005-2015
- Breast cancer, crude incidence rate, females, 2005-2015

- Col uteri cancer, crude incidence rate, females, 2005-2015
- Corpus uteri cancer, crude incidence rate, females, 2005-2015
- Ovary cancer, crude incidence rate, females, 2005-2015

- Prostate cancer, crude incidence rate, males, 2005-2015
- Testis cancer, crude incidence rate, males, 2005-2015

- Kidney cancer, crude incidence rate, males, 2005-2015
- Kidney cancer, crude incidence rate, females, 2005-2015

- Bladder cancer, crude incidence rate, males, 2005-2015
- Bladder cancer, crude incidence rate, females, 2005-2015

- Brain and central nervous system cancer, crude incidence rate, males, 2005-2015
- Brain and central nervous system cancer, crude incidence rate, females, 2005-2015

- Thyroid cancer, crude incidence rate, males, 2005-2015
- Thyroid cancer, crude incidence rate, females, 2005-2015

- Hodgkin's lymphoma, crude incidence rate, males, 2005-2015
- Hodgkin's lymphoma, crude incidence rate, females, 2005-2015

- Non-Hodgkin lymphoma, crude incidence rate, males, 2005-2015
- Non-Hodgkin lymphoma, crude incidence rate, females, 2005-2015

- Lymphoma all types, crude incidence rate, males, 2005-2015
- Lymphoma all types, crude incidence rate, females, 2005-2015

- Multiple myeloma, crude incidence rate, males, 2005-2015
- Multiple myeloma, crude incidence rate, females, 2005-2015

- Lymphoid leukemia, crude incidence rate, males, 2005-2015
- Lymphoid leukemia, crude incidence rate, females, 2005-2015

- Myeloid leukemia, crude incidence rate, males, 2005-2015
- Myeloid leukemia, crude incidence rate, females, 2005-2015

- Leukemia all types, crude incidence rate, males, 2005-2015
- Leukemia all types, crude incidence rate, females, 2005-2015

 
    1
    ...
    57
    58
    59
    60
    61
    62
    ...
    183
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
C01CA26 EPHEDRINE AGUETTANT G Ephedrine HCl - 30mg/ml 30mg/ml Injectable solution 614,136 L.L
C01CA26 EPHEDRINE RENAUDIN G Ephedrine HCl - 30mg/ml 3% Injectable solution 693,423 L.L
C01CA26 EPHEDRINE AGUETTANT G Ephedrine HCl - 3mg/ml 3mg/ml Injectable solution 7,827,491 L.L
C01CA24 ADRENALINE RENAUDIN G Epinephrine (tartrate) - 1mg/ml 1mg Injectable solution 444,812 L.L
L01DB03 EPIRUBICINE VIATRIS 2MG/ML G Epirubicin HCl - 10mg/5ml 10mg/5ml Injectable solution 822,636 L.L
L01DB03 EPIRUBICINE VIATRIS 2MG/ML G Epirubicin HCl - 50mg/25ml 50mg/25ml Injectable solution 3,765,140 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 25mg 25mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 25mg 25mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 25mg 25mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE BIOGARAN G Eplerenone - 25mg 25mg Tablet, coated 1,849,127 L.L
C03DA04 HEPERONA 25 G Eplerenone - 25mg 25mg Tablet, coated 2,116,552 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 50mg 50mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 50mg 50mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE ARROW G Eplerenone - 50mg 50mg Tablet, coated 1,744,308 L.L
C03DA04 EPLERENONE BIOGARAN G Eplerenone - 50mg 50mg Tablet, coated 1,849,127 L.L
C03DA04 HEPERONA 50 G Eplerenone - 50mg 50mg Tablet, coated 2,150,148 L.L
B02BD08 RECOFACT VII BioTech Eptacog alfa (activated) recombinant - 1.2mg 1.2mg Injectable powder for solution+diluent 47,533,131 L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 1mg 1mg (50KIU) Injectable powder for solution+diluent L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 1mg 1mg (50KIU) Injectable powder for solution+diluent 57,890,287 L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 2mg 2mg (100KIU) Injectable powder for solution+diluent 105,957,406 L.L
B02BD08 NOVOSEVEN RT BioTech Eptacog alfa (activated) recombinant - 5mg 5mg (250KIU) Injectable powder for solution+diluent 264,894,762 L.L
B02BD08 ARYOSEVEN RT BioTech Eptacog alfa - 1mg 1mg Injectable powder for solution+diluent L.L
B02BD08 ARYOSEVEN RT BioTech Eptacog alfa - 1mg 1mg Injectable powder for solution+diluent 16,902,713 L.L
N02CD01 AIMOVIG BioTech Erenumab - 70mg/ml 70mg/ml Injectable solution 35,423,371 L.L
L01XX41 HALAVEN B Eribulin mesylate - 0.88mg/2ml 0.88mg/2ml Injectable solution L.L
L01XX41 HALAVEN B Eribulin mesylate - 0.88mg/2ml 0.88mg/2ml Injectable solution 38,083,434 L.L
L01EB02 APO-ERLOTINIB G Erlotinib (HCl) - 100mg 100mg Tablet 79,672,726 L.L
L01EB02 MIRATA G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 77,379,009 L.L
L01EB02 TARESSA 100 G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 82,247,256 L.L
L01EB02 APO-ERLOTINIB G Erlotinib (HCl) - 150mg 150mg Tablet 91,523,229 L.L
    1
    ...
    57
    58
    59
    60
    61
    62
    ...
    183
Sitemap
© Copyrights reserved to Ministry of Public Health 2025